Skip to main content
. Author manuscript; available in PMC: 2021 Jul 6.
Published in final edited form as: AJR Am J Roentgenol. 2019 Oct 15;214(1):105–113. doi: 10.2214/AJR.19.21264

TABLE 4:

Comparison of Normalized Signal Intensity (SI) Percentage Changes in Metastatic Lymph Nodes (LNs) on MR Lymphography (MRL) Performed Before and After Ferumoxytol Injection by Postinjection Time Point and Cancer Type

95% Confidance Limits
Postinjection MRL Time Point, Cancer Type Value SE Lower Upper
Normalized SI percentage change in metastatic LNs from preinjection MRL to postinjection MRL (%)
 24 Hours after ferumoxytol injection
  Prostate cancer −36.4 3.1 −42.5 −30.4
  Renal cancer −26.7 7.6 −41.5 −11.9
  Bladder cancer −21.1 9.7 −40.1 −2.1
 48 Hours after ferumoxytol injection
  Prostate cancer −29.0 5.1 −39.0 −19.1
  Renal cancer −26.4 13.5 −52.8 0.0
  Bladder cancer −10.3 16.6 −42.8 22.3

Note—SE = standard error.